clinical depression

J&J builds case for ketamine-based depression drug
J&J builds case for ketamine-based depression drug
Biopharma Dive
JNJ
esketamine
ketamine
clinical depression
Flag link:
Allergan, Gedeon Richter plan depression submission
Allergan, Gedeon Richter plan depression submission
BioPharma Dive
Allergan
Gedeon
clinical depression
Vraylar
acute bipolar depression
Flag link:
Don't give up on tough-to-treat depression, Janssen R&D says in new video push
Don't give up on tough-to-treat depression, Janssen R&D says in new video push
Fierce Pharma
clinical depression
Janssen
R&D
JNJ
Flag link:
J&J beefs up neuro pipeline, bags a new depression drug from Cerecor in $45M deal
J&J beefs up neuro pipeline, bags a new depression drug from Cerecor in $45M deal
Endpoints
JNJ
Cerecor
CERC-501
clinical depression
Flag link:
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Endpoints
Neuralstem
clinical trials
NSI-189
clinical depression
Flag link:
Allergan To Test Botox For Depression Despite Mixed Results
Allergan To Test Botox For Depression Despite Mixed Results
Forbes
Allergan
Botox
clinical depression
clinical trials
Flag link:
Tech-focused Takeda pilots Apple Watch trial to collect depression data
Tech-focused Takeda pilots Apple Watch trial to collect depression data
Fierce Pharma
Takeda
Apple
Apple Watch
clinical depression
wearables
Flag link:
Allergan eyes depression as blockbuster Botox's next big stage
Allergan eyes depression as blockbuster Botox's next big stage
Fierce Pharma
Allergan
Botox
clinical depression
Flag link:
Pfizer creates app for patients with depression
Pfizer creates app for patients with depression
Medical Marketing and Media
Pfizer
clinical depression
apps
mobile medical apps
Pristiq
Flag link:
Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater
Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater
Endpoints
Cerecor
clinical depression
clinical trials
CERC-501
Eli Lilly
Alkermes
Flag link:
A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA
A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA
Forbes
biotech
FDA
Alkermes
clinical depression
ALKS 5461
antidepressants
Flag link:
Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression
Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression
Forbes
Alkermes
Richard Pops
ALKS 5461
clinical depression
Flag link:
Alkermes slammed as top depression drug fails two PhIIIs
Alkermes slammed as top depression drug fails two PhIIIs
Fierce Biotech
Alkermes
ALKS-5461
clinical depression
clinical trials
Flag link:
J&J halts a depression program in the shadow of fatal French trial
J&J halts a depression program in the shadow of fatal French trial
Fierce Biotech
JNJ
clinical depression
JNJ-42165279
clinical trials
Flag link:
Slow Sales Uptake For Brintellix Show The Challenges Facing New Depression Drugs
Slow Sales Uptake For Brintellix Show The Challenges Facing New Depression Drugs
Forbes
clinical depression
Brintellix
Lundbeck
Flag link:
Botox Seems To Ease Depression
Botox Seems To Ease Depression
Forbes
Botox
clinical depression
Allergan
Actavis
Flag link:
J&J team marks another setback on depression as midstage study flops
J&J team marks another setback on depression as midstage study flops
Fierce Biotech
JNJ
clinical depression
ADX71149
Addex
antidepressants
Flag link:
Shire scraps Vyvanse for depression after failed trials
Shire scraps Vyvanse for depression after failed trials
Yahoo/Reuters
Shire
Vyvanse
ADHD
clinical depression
Flag link:
Small Companies Are Leading Innovation For New Drugs To Treat Depression
Small Companies Are Leading Innovation For New Drugs To Treat Depression
Forbes
clinical depression
Lundbeck
Alkermes
Novartis
Pfizer
AstraZeneca
Merck
Sanofi
Flag link: